The estimated Net Worth of Patrick B Verguet is at least 20.3 百万$ dollars as of 31 May 2017. Patrick Verguet owns over 10,000 units of Edwards Lifesciences Corp stock worth over 9,496,100$ and over the last 20 years Patrick sold EW stock worth over 10,797,045$.
Patrick has made over 60 trades of the Edwards Lifesciences Corp stock since 2011, according to the Form 4 filled with the SEC. Most recently Patrick exercised 10,000 units of EW stock worth 446,200$ on 31 May 2017.
The largest trade Patrick's ever made was exercising 32,337 units of Edwards Lifesciences Corp stock on 16 May 2016 worth over 331,131$. On average, Patrick trades about 7,227 units every 25 days since 2005. As of 31 May 2017 Patrick still owns at least 139,137 units of Edwards Lifesciences Corp stock.
You can see the complete history of Patrick Verguet stock trades at the bottom of the page.
Patrick's mailing address filed with the SEC is C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE, CA, 92614.
Over the last 21 years, insiders at Edwards Lifesciences Corp have traded over 94,964,396$ worth of Edwards Lifesciences Corp stock and bought 47,398 units worth 3,992,090$ . The most active insiders traders include Michael A Mussallem、Donald E Jr Bobo、Steven R Loranger. On average, Edwards Lifesciences Corp executives and independent directors trade stock every 8 days with the average trade being worth of 1,126,057$. The most recent stock trade was executed by Donald E Jr Bobo on 11 September 2024, trading 5,000 units of EW stock currently worth 226,400$.
edwards lifesciences (nyse: ew) is the global leader in the science of heart valves and hemodynamic monitoring. driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that save and enhance lives. headquartered in irvine, california, edwards lifesciences has extensive operations in north america, europe, japan, latin america and asia and currently employs about 6,400 individuals worldwide. for us, helping patients is not a slogan – it's our life’s work. from developing devices that replace or repair a diseased heart valve to creating new technologies that monitor vital signs in the critical care setting, we help ensure that patients regain and even improve their quality of life.
Edwards Lifesciences Corp executives and other stock owners filed with the SEC include: